159 related articles for article (PubMed ID: 31262862)
1. State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
Balsano R; Tommasi C; Garajova I
Anticancer Res; 2019 Jul; 39(7):3405-3412. PubMed ID: 31262862
[TBL] [Abstract][Full Text] [Related]
2. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer.
Caparello C; Meijer LL; Garajova I; Falcone A; Le Large TY; Funel N; Kazemier G; Peters GJ; Vasile E; Giovannetti E
World J Gastroenterol; 2016 Aug; 22(31):6987-7005. PubMed ID: 27610011
[TBL] [Abstract][Full Text] [Related]
3. [Recent update of molecular targeted therapy in pancreatic cancer].
Cho JH
Korean J Gastroenterol; 2013 Mar; 61(3):147-54. PubMed ID: 23575233
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for pancreatic cancer.
Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
[TBL] [Abstract][Full Text] [Related]
5. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets.
Sclafani F; Iyer R; Cunningham D; Starling N
Crit Rev Oncol Hematol; 2015 Sep; 95(3):318-36. PubMed ID: 25921418
[TBL] [Abstract][Full Text] [Related]
6. Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review.
Garcia G; Odaimi M
J Gastrointest Cancer; 2017 Jun; 48(2):121-128. PubMed ID: 28303435
[TBL] [Abstract][Full Text] [Related]
7. Current treatment landscape and emerging therapies for pancreatic cancer.
Adel N
Am J Manag Care; 2019 Jan; 25(1 Suppl):S3-S10. PubMed ID: 30681819
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to target pancreatic cancer.
Porzner M; Seufferlein T
Curr Cancer Drug Targets; 2011 Jul; 11(6):698-713. PubMed ID: 21599630
[TBL] [Abstract][Full Text] [Related]
9. New target therapies in advanced pancreatic cancer.
Cascinu S; Verdecchia L; Valeri N; Berardi R; Scartozzi M
Ann Oncol; 2006 May; 17 Suppl 5():v148-52. PubMed ID: 16807445
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant Chemotherapy after Surgery for Pancreatic Cancer].
Furuse J
Gan To Kagaku Ryoho; 2016 Feb; 43(2):160-4. PubMed ID: 27067680
[TBL] [Abstract][Full Text] [Related]
11. Current and Evolving Therapies for Metastatic Pancreatic Cancer: Are We Stuck With Cytotoxic Chemotherapy?
Varadhachary GR; Wolff RA
J Oncol Pract; 2016 Sep; 12(9):797-805. PubMed ID: 27621332
[TBL] [Abstract][Full Text] [Related]
12. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
13. Development of poly(ADP-ribose) polymerase inhibitors in the treatment of BRCA-mutated breast cancer.
Sulai NH; Tan AR
Clin Adv Hematol Oncol; 2018 Jul; 16(7):491-501. PubMed ID: 30067621
[TBL] [Abstract][Full Text] [Related]
14. New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers.
Diaz-Rubio E
Oncologist; 2004; 9(3):282-94. PubMed ID: 15169983
[TBL] [Abstract][Full Text] [Related]
15. [Chemoradiotherapy for Locally Advanced Pancreatic Cancer].
Okano N; Kawai K; Naruge D; Kitamura H; Nagashima F; Furuse J
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1152-5. PubMed ID: 26489544
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.
Rubinson DA; Wolpin BM
Hematol Oncol Clin North Am; 2015 Aug; 29(4):761-76. PubMed ID: 26226909
[TBL] [Abstract][Full Text] [Related]
17. [Systemic treatments of metastatic or locally recurrent adenoid cystic carcinoma of the head and neck, a systematic review].
Cherifi F; Rambeau A; Johnson A; Florescu C; Géry B; Babin E; Thariat J
Bull Cancer; 2019 Oct; 106(10):923-938. PubMed ID: 31324333
[TBL] [Abstract][Full Text] [Related]
18. Perspectives in the treatment of pancreatic adenocarcinoma.
Cid-Arregui A; Juarez V
World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis.
Liu GF; Li GJ; Zhao H
J Cell Biochem; 2018 Jan; 119(1):511-523. PubMed ID: 28608558
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols.
Abendroth A; Noureddine R; Abramczyk M; Paul A; Gerken G; Schmid KW; Markus P; Schumacher B; Wiesweg M; Köhler J; Markus M; Mende B; Dechêne A; Schuler M; Kasper S
J Cancer Res Clin Oncol; 2019 Feb; 145(2):445-455. PubMed ID: 30430229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]